Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: Improving surgery and outcome in focal hyperinsulinism

Hormone Research

Volumn 66, Issue 1, 2006, Pages 43-44

  Shield, Julian P H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; AROMATIC LEVO AMINO ACID DECARBOXYLASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

DIABETES MELLITUS; DIAGNOSTIC IMAGING; GENE MUTATION; HUMAN; ISOTOPE LABELING; NOTE; PANCREAS RESECTION; PANCREAS SCINTISCANNING; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

CONSENSUS DEVELOPMENT CONFERENCES; DIAGNOSIS, DIFFERENTIAL; FLUORINE RADIOISOTOPES; HUMANS; INFANT; LEVODOPA; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 33745457469     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093472     Document Type: Note

References (22)

1. Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E: Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003;149:43-51.
2. Jack MM, Greer RM, Thomsett MJ, et al: The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes. Clin Endocrinol (Oxf) 2003;58:355-364.
3. Menni F, de Lonlay P, Sevin C, et al: Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001;107:476-479.
4. Cherian MP, Abduljabbar MA: Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab 2005;18:1441-1448.
5. Levitt NS, Adams G, Salmon J, et al: The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM. Diabetes Care 1995;18:971-974.
6. Cohen MM Jr: Persistent hyperinsulinemic hypoglycemia of infancy. Am J Med Genet A 2003;122:351-353.
7. Thomas P, Ye Y, Lightner E: Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996;5:1809-1812.
8. Glaser B, Kesavan P, Heyman M, et al: Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998;338:226-230.
9. Stanley CA, Lieu YK, Hsu BY, et al: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 1998;338:1352-1357.
10. Stanley CA, Thornton PS, Ganguly A, et al: Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004;89:288-296.
11. Verkarre V, Fournet JC, de Lonlay P, et al: Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998;102:1286-1291.
12. Fournet JC, Mayaud C, de Lonlay P, et al: Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 2001;158:2177-2184.
13. Cretolle C, Fekete CN, Jan D, et al: Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: a report of 45 cases from 1983 to 2000. J Pediatr Surg 2002;37:155-158.
14. Dubois J, Brunelle F, Touati G, et al: Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25:512-516.
15. Chigot V, De Lonlay P, Nassogne MC, et al: Pancreatic arterial calcium stimulation in the diagnosis and localisation of persistent hyperinsulinemic hypoglycaemia of infancy. Pediatr Radiol 2001;31:650-655.
16. 18F]-DOPA positron emission tomography. Diabetes 2006;55:13-18.
17. Soria B, Andreu E, Berna G, et al: Engineering pancreatic islets. Pflugers Arch 2000;440:1-18.
18. Ericson LE, Hakanson R, Lundquist I: Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia 1977;13:117-124.
19. Borelli MI, Villar MJ, Orezzoli A, Gagliardino JJ: Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab 1997;23:161-163.
20. Fekete CN, de Lonlay P, Jaubert F, Rahier J, Brunelle F, Saudubray JM: The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg 2004;39:267-269.
21. 18F-fluoro-L-DOPA. J Nucl Med 2005;46:560-566.
22. 18F] fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 2006;91:933-940.